Numerical aberrations of chromosome 17 and TP53 in brain metastases derived from breast cancer

Genetics and Molecular Research

Volumn 12, Issue 3, 2013, Pages 2594-2600

  de Oliveira, E H C ^a,e   Vasconcelos, D S ^a   da Silva, F P E ^a,b   Quintana, L G ^a   Anselmo, N P ^c   Othman, M A K ^d   Liehr, T ^d  

^a FEDERAL UNIVERSITY OF PARÁ   (Brazil)

^b Instituto Federal de Educacao   (Brazil)

^c Instituto de Ciencias Biologicas   (Brazil)

^d JENA UNIVERSITY HOSPITAL   (Germany)

^e INSTITUTO EVANDRO CHAGAS   (Brazil)

Author keywords

Breast cancer; Chromosome 17; Fish; Metastasis; Tp53 gene

Indexed keywords

PROTEIN P53;

ADULT; ARTICLE; BRAIN METASTASIS; BREAST ADENOCARCINOMA; CANCER PROGNOSIS; CARCINOGENESIS; CHROMOSOME 17; CLINICAL ARTICLE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE DELETION; GENE DOSAGE; GENE LOSS; HUMAN; HUMAN TISSUE; METASTASIS POTENTIAL; NUMERICAL CHROMOSOME ABERRATION; PRIMARY TUMOR; TP53 GENE; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ADULT; BRAIN NEOPLASMS; BREAST NEOPLASMS; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 17; FEMALE; GENE DELETION; HUMANS; MIDDLE AGED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84880945036     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2013.January.4.15     Document Type: Article

References (29)

1. Barnholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, et al. (2004). Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J. Clin. Oncol. 22: 2865-2872.
2. Bos PD, Zhang XH, Nadal C, Shu W, et al. (2009). Genes that mediate breast cancer metastasis to the brain. Nature 459: 1005-1009.
3. Cambruzzi E, Pêgas KL and Ferrari MB (2011). Avaliação imuno-histoquímica de 100 casos de metástases encefálicas e correlação com o sítio primário do tumor. J. Bras. Patol. Med. Lab. 47: 57-64.
4. Cheng X and Hung MC (2007). Breast cancer brain metastases. Cancer Metastasis Rev. 26: 635-643.
5. Chiang AC and Massagué J (2008). Molecular basis of metastasis. N. Engl. J. Med. 359: 2814-2823.
6. Espinosa AB, Tabernero MD, Maillo A, Sayagues JM, et al. (2006). The cytogenetic relationship between primary and recurrent meningiomas points to the need for new treatment strategies in cases at high risk of relapse. Clin. Cancer Res. 12: 772-780.
7. Fadl-Elmula I (2005). Chromosomal changes in uroepithelial carcinomas. Cell Chromosome 4: 1.
8. Fidler IJ (2003). The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat. Rev. Cancer 3: 453 458.
9. Fulford LG, Reis-Filho JS, Ryder K, Jones C, et al. (2007). Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival. Breast Cancer Res. 9: R4.
10. Gadea G, de Toledo M, Anguille C and Roux P (2007). Loss of p53 promotes RhoA-ROCK-dependent cell migration and invasion in 3D matrices. J. Cell Biol. 178: 23-30.
11. Gagos S and Irminger-Finger I (2005). Chromosome instability in neoplasia: chaotic roots to continuous growth. Int. J. Biochem. Cell Biol. 37: 1014-1033.
12. Guo F and Zheng Y (2004). Rho family GTPases cooperate with p53 deletion to promote primary mouse embryonic fibroblast cell invasion. Oncogene 23: 5577-5585.
13. Hopman AH, Voorter CE and Ramaekers FC (1994). Detection of genomic changes in cancer by in situ hybridization. Mol. Biol. Rep. 19: 31-44.
14. INCA (2012). Instituto Nacional do Câncer. Available at [http://www.inca.gov.br]. Accessed January 20, 2012.
15. Lohr F, Pirzkall A, Hof H, Fleckenstein K, et al. (2001). Adjuvant treatment of brain metastases. Semin. Surg. Oncol. 20: 50-56.
16. Marko NF, Xu Z, Gao T, Kattan MW, et al. (2012). Predicting survival in women with breast cancer and brain metastasis: A nomogram outperforms current survival prediction models. Cancer 118: 3749-3757.
17. Meszaros N, Belengeanu D, Stoicanescu D, Andreescu N, et al. (2010). Analysis of numerical aberrations of chromosome 17 and tp53 gene deletion/amplification in human oral squamous cell carcinoma using dual-color fluorescence in situ hybridization. Anal. Univ. Oradea - Fascicula Biologie XVII/1: 142-146.
18. Muller PA, Vousden KH and Norman JC (2011). p53 and its mutants in tumor cell migration and invasion. J. Cell Biol. 192: 209-218.
19. Paget S (1889). The distribution of secondary growths in cancer of the breast. Lancet 133: 571-573.
20. Pandis N, Teixeira MR, Adeyinka A, Rizou H, et al. (1998). Cytogenetic comparison of primary tumors and lymph node metastases in breast cancer patients. Genes Chromosomes Cancer 22: 122-129.
21. Qin Q, Baudry M, Liao G, Noniyev A, et al. (2009). A novel function for p53: regulation of growth cone motility through interaction with Rho kinase. J. Neurosci. 29: 5183-5192.
22. Reinholz MM, Bruzek AK, Visscher DW, Lingle WL, et al. (2009). Breast cancer and aneusomy 17: implications for carcinogenesis and therapeutic response. Lancet Oncol. 10: 267-277.
23. Rosenberg C, Andersen TI, Nesland JM, Lier ME, et al. (1994). Genetic alterations of chromosome 17 in human breast carcinoma studied by fluorescence in situ hybridization and molecular DNA techniques. Cancer Genet. Cytogenet. 75: 1-5.
24. Saunus JM, Momeny M, Simpson PT, Lakhani SR, et al. (2011). Molecular aspects of breast cancer metastasis to the brain. Genet. Res. Int. 2011: 9.
25. Talmadge JE and Fidler IJ (2010). AACR centennial series: The biology of cancer metastasis: Historical perspective. Cancer Res. 70: 5649-5669.
26. Tham YL, Sexton K, Kramer R, Hilsenbeck S, et al. (2006). Primary breast cancer phenotypes associated with propensity for central nervous system metastases. Cancer 107: 696-704.
27. Tsuda H, Sakamaki C, Tsugane S, Fukutomi T, et al. (1998). A prospective study of the significance of gene and chromosome alterations as prognostic indicators of breast cancer patients with lymph node metastases Breast Cancer. Res. Treat. 48: 21-32.
28. Weil RJ, Palmieri DC, Bronder JL, Stark AM, et al. (2005). Breast cancer metastasis to the central nervous system. Am. J. Pathol. 167: 913-920.
29. Zhang W and Yu Y (2011). The important molecular markers on chromosome 17 and their clinical impact in breast cancer. Int. J. Mol. Sci. 12: 5672-5683.